Investorideas.com Newswire

Investorideas.com Newswire
Be one of the most talked about companies (stocks) on social media

Investorideas.com newswire, biotech stocks and industry

Wednesday, August 4, 2010

Investorideas.com - Biotech Stocks and Tech Stocks: OTC Volume Leaders Most Active ($2.00-$5.00): (OTCBB: FKWL), (OTCBB: NEOP), (OTCBB: FTLUF), (OTCBB: MASC)

Investorideas.com - Biotech Stocks and Tech Stocks: OTC Volume Leaders Most Active ($2.00-$5.00): (OTCBB: FKWL), (OTCBB: NEOP), (OTCBB: FTLUF), (OTCBB: MASC)

Follow more OTCBB stocks by clicking the sign up link below or go to otcvolumeleaders.com
Note to Editors: The Following Is an Investment Opinion Being Issued by OTC VOLUME LEADERS
Subscribe to Investor Ideas Newswire


Visit this company: www.otcvolumeleaders.com


Point Roberts, WA (Investorideas.com Newswire) August 4, 2010 - OTC VOLUME LEADERS reports on the most active trading stocks on the OTCBB. OTC Volume leaders ($2.00-$5.00) include Franklin Wireless Corp (OTCBB: FKWL), Neoprobe Corp. (OTCBB: NEOP), FUNTALK CHINA HLDG (OTCBB: FTLUF), and Material Sciences Corporation (OTCBB: MASC).


Click below to sign up for Free list of Tomorrows Hot OTC Market Leaders!http://bit.ly/otcvolumeleaders
OTC / Market Commentary:
Sectors include Biotech and Tech Stocks
One of the OTCBB volume leaders; Neoprobe Corp. (OTCBB: NEOP): "Neoprobe is a biomedical company focused on enhancing patient care and improving patient outcome by meeting the critical intraoperative diagnostic information needs of physicians and therapeutic treatment needs of patients. Neoprobe currently markets the neoprobe® GDS line of gamma detection systems that are widely used by cancer surgeons. In addition, Neoprobe holds significant interests in the development of related biomedical systems and radiopharmaceutical agents including Lymphoseek® and RIGScan™ CR. Neoprobe’s subsidiary, Cira Biosciences, Inc., is also advancing a patient-specific cellular therapy technology platform called ACT. Neoprobe’s strategy is to deliver superior growth and shareholder return by maximizing its strong position in gamma detection technologies and diversifying into new, synergistic biomedical markets through continued investment and selective acquisitions. www.neoprobe.com"


Market Snapshot: (at time of release)
Dow 10,660.83 +24.45 +0.23%
Nasdaq 2,294.34 +10.82 +0.47%
S&P 500 1,123.62 +3.16 +0.28%
10 Yr Bond(%) 2.9460% +0.3200
Oil 82.21 -0.34 -0.41%
Gold 1,194.80 +9.60 +0.81%


OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.
OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today!
OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader
Visit the OTC showcase profile at Investorideas.com Request News and Info on OTC Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.
More Info:
Published at www.Investorideas.com - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.


Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

No comments:

Post a Comment